FDA warns Medline, Inc., about CGMP violations in its manufacturing of drugs at its Waukegan, IL, facility.
FDA warns Mexico’s Laboratorios Jaloma about CGMP violations in its production of finished drugs.
FDA warns Medline, Inc., about CGMP violations in its manufacturing of drugs at its Waukegan, IL, facility.
FDA warns Mexico’s Laboratorios Jaloma about CGMP violations in its production of finished drugs.
FDA publishes a draft question-and-answer guidance on manufacturer communication of health care economic information to payors.
FDA makes available an International Council for Harmonization guidance that establishes a global framework for using computational modeling and simulation in drug development.
